Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ursodeoxycholic Acid (UDCA) as Adjuvant Treatment for Rhegmatogenous Retinal Detachment: a Phase I Pilot Study

NCT02841306 is registered in ClinicalTrials.gov with Francine Behar-Cohen as lead sponsor.

NCT NCT02841306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02841306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ursodeoxycholic Acid (UDCA) as Adjuvant Treatment for Rhegmatogenous Retinal Detachment: a Phase I Pilot Study
Lead sponsor
Francine Behar-Cohen
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2016
Completion date
September 30, 2017
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rhegmatogenous retinal detachment